Goodpasture’s syndrome
Goodpasture’s syndrome
Goodpastures syndrome
An autoimmune disease of the kidney and the lung. It is characterized by the presence of circulating autoantibodies targeting the epitopes in the non-collagenous domains of collagen type iv in the basement membranes of kidney glomeruli kidney glomerulus) and lung alveoli pulmonary alveoli), and the subsequent destruction of these basement membranes. Clinical features include pulmonary alveolar hemorrhage and glomerulonephritis.
An autoimmune disorder characterized by pulmonary hemorrhage and glomerulonephritis. It is a hypersensitivity reaction resulting in the formation of antibodies against the pulmonary alveoli and the basement membrane of the glomeruli.
An autoimmune disorder characterized by the production of autoantibodies against type iv collagen of the glomerular basement membrane of the kidney. In the majority of patients the immune reaction also extends to the alveolar capillary membrane of the lungs. The latter cases are referred to as goodpasture syndrome.
Combination of pulmonary hemorrhage and glomerulonephritis; known also as the lung purpura glomerulonephritis complex; considered by some to be a form of hypersensitivity reaction.
Disorder characterized by a vasculitic syndrome associated with exposure to an antigen such as a drug, infectious agent, or other foreign or endogenous substance. Its pathophysiology includes immune complex deposition and a wide range of skin lesions. Hypersensitivity or allergy is present in some but not all cases.
M31.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2023 edition of ICD-10-CM M31.0 became effective on October 1, 2022.
This is the American ICD-10-CM version of M31.0 – other international versions of ICD-10 M31.0 may differ.